CRUCIANI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 12.819
EU - Europa 7.902
AS - Asia 7.281
SA - Sud America 1.180
Continente sconosciuto - Info sul continente non disponibili 648
AF - Africa 207
OC - Oceania 9
Totale 30.046
Nazione #
US - Stati Uniti d'America 12.289
SG - Singapore 3.406
IT - Italia 1.386
UA - Ucraina 1.214
IE - Irlanda 1.169
CN - Cina 1.029
SE - Svezia 1.025
RU - Federazione Russa 968
HK - Hong Kong 880
BR - Brasile 871
VN - Vietnam 720
DE - Germania 487
FR - Francia 477
FI - Finlandia 372
GB - Regno Unito 313
KR - Corea 281
CA - Canada 209
IN - India 156
BD - Bangladesh 145
TR - Turchia 113
AR - Argentina 92
JP - Giappone 84
PL - Polonia 78
MX - Messico 73
NL - Olanda 67
PK - Pakistan 61
IQ - Iraq 60
AT - Austria 59
EC - Ecuador 58
ZA - Sudafrica 58
CO - Colombia 54
ES - Italia 50
MA - Marocco 45
UZ - Uzbekistan 44
BE - Belgio 40
CR - Costa Rica 40
CH - Svizzera 38
VE - Venezuela 38
IL - Israele 36
PH - Filippine 36
GR - Grecia 31
ID - Indonesia 31
SA - Arabia Saudita 30
SV - El Salvador 30
GT - Guatemala 27
HN - Honduras 27
AE - Emirati Arabi Uniti 25
CW - ???statistics.table.value.countryCode.CW??? 25
CL - Cile 24
MY - Malesia 22
PR - Porto Rico 22
TT - Trinidad e Tobago 22
JM - Giamaica 20
RO - Romania 19
NI - Nicaragua 18
CZ - Repubblica Ceca 16
JO - Giordania 16
KE - Kenya 16
LT - Lituania 15
LB - Libano 14
PE - Perù 13
EU - Europa 12
PY - Paraguay 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
EE - Estonia 11
KZ - Kazakistan 11
SC - Seychelles 11
AZ - Azerbaigian 10
EG - Egitto 10
ET - Etiopia 10
UY - Uruguay 10
NP - Nepal 9
OM - Oman 9
AL - Albania 8
PT - Portogallo 8
TN - Tunisia 8
BO - Bolivia 7
MD - Moldavia 7
PA - Panama 7
TH - Thailandia 7
DK - Danimarca 6
GE - Georgia 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
AM - Armenia 5
AU - Australia 5
BB - Barbados 5
BG - Bulgaria 5
GP - Guadalupe 5
KW - Kuwait 5
RS - Serbia 5
SN - Senegal 5
CI - Costa d'Avorio 4
HU - Ungheria 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
AO - Angola 3
BF - Burkina Faso 3
BN - Brunei Darussalam 3
Totale 29.362
Città #
Singapore 2.354
Chandler 1.473
Dublin 1.168
Ashburn 1.132
San Jose 1.062
Hong Kong 872
Jacksonville 611
San Mateo 530
Boardman 482
Santa Clara 470
Perugia 391
Council Bluffs 386
Dong Ket 331
Moscow 319
Princeton 281
Medford 278
Seoul 277
Beijing 274
Lauterbourg 269
Altamura 250
Lawrence 208
Los Angeles 197
Wilmington 196
Des Moines 190
Ann Arbor 187
The Dalles 166
Andover 157
New York 143
Munich 134
Ho Chi Minh City 131
Fremont 127
Dallas 105
Piscataway 97
São Paulo 89
Saint Petersburg 84
Hanoi 82
Tokyo 79
Helsinki 77
Rome 65
Turku 60
Orem 58
Philadelphia 58
North Bergen 57
Montreal 51
Izmir 49
Milan 48
Atlanta 47
Denver 45
Shanghai 45
London 43
Phoenix 42
San Francisco 42
San Paolo di Civitate 42
Warsaw 41
Norwalk 40
Brooklyn 38
Chicago 38
Columbus 38
Brussels 37
Woodbridge 37
Toronto 36
Houston 35
Belo Horizonte 33
Falls Church 31
Redmond 31
Johannesburg 30
San José 30
Boston 29
Frankfurt am Main 28
Stockholm 28
Chennai 27
San Salvador 26
Florence 25
Willemstad 25
Charlotte 24
Nuremberg 24
Seattle 24
Bologna 23
San Diego 23
Buffalo 22
Mexico City 22
Amsterdam 21
Naples 21
Guatemala City 20
Hefei 20
Poplar 20
Tashkent 20
Washington 20
Baghdad 19
Caracas 19
Manchester 19
Mumbai 19
Bogotá 18
Guayaquil 18
Rio de Janeiro 18
Ankara 17
Brasília 17
Da Nang 17
Kingston 17
Managua 17
Totale 17.613
Nome #
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs 299
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets 268
Physical Activity Modulates the Overexpression of the Inflammatory miR-146a-5p in Obese Patients 240
Discovery and Structure–Activity Relationships of Novel ssDAF-12 Receptor Modulators 186
A 3D-QSAR Study on the Srtuctural Requirements for Binding to CB1 and CB2 Cannabinoid Receptors 171
3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands 162
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 156
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 155
BioGPS: Navigating biological space to predict polypharmacology, off-targeting, and selectivity 155
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 154
6-Substituted Benzopyrans as Potassium Channel Activators: Synthesis, Vasodilator Properties, and Multivariate Analysis 153
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 150
3D-QSAR GRID Descriptors and Chemometric Tools in the development of Selective Antagonists of Muscarinic Receptor 146
Conformer- and Alignment-Independent Model for Predicting Structurally Diverse Competitive CYP2C9 Inhibitors 146
Fluorinated analogues of Bosentan: effects on the antagonist activity and the metabolic stability 146
A comparative study of the antimicrobial and antioxidant activities of Inonotus hispidus fruit and their mycelia extracts 146
Autocorrelation as a tool for a congruent description of molecu¬les in 3D-QSAR studies 145
A quantitative fluorimetric analysis of a multicomponent system based on a modified PCA-SM method 144
Inhibitor of Ovarian Cancer Cells Growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 144
Analytical strategies to assess the functional metabolome of vitamin E 142
Application of chemometrics to the screening of hazardous chemicals. A case study 140
La chemiometria nell'ottimizzazione dei prodotti alimentari 139
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists 139
Overview of the biological activities of a methanol extract from wild red belt conk, fomitopsis Pinicola (Agaricomycetes), fruiting bodies from central Italy 139
Lipostar, a comprehensive platform-neutral cheminformatics tool for lipidomics 138
Absolute configuration and biological profile of two thiazinooxadiazol-3-ones with L-type calcium channel activity: a study of the structural effects 137
Vitamin E: metabolism and molecular aspects 136
Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening 135
Hydrogen Bonding Interactions of Covalently-Bonded Fluorine Atoms: From Crystallographic Data to a New Angular Function in the GRID Force Field 135
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 134
Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications 134
Structure-metabolism relationships in human-AOX: Chemical insights from a large database of aza-aromatic and amide compounds 133
Application of the PLS method to develop quantitative predictive models in toxicology and ecotoxicology 132
A chemometric approach for evaluating the efficiency of a pilot plant for MSW combustion 132
Amniotic fluid stem cell-derived extracellular vesicles educate type 2 conventional dendritic cells to rescue autoimmune disorders in a multiple sclerosis mouse model 131
Calcium channel antagonists discovered by a multidisciplinary approach 130
Principal Properties of aromatic substituents. A multivariate approach for design in QSAR 130
3D QSAR of Mutagenic Heterocyclic Amines that are Substrates of Cytochrome P458 1A2 129
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 129
Interaction of DDSDEEN peptide with N-CAM protein. Possible mechanism enhancing neuronal differentiation 127
Suitability of molecular descriptors for database mining. A comparative analysis. 126
Diagnostic application of lipidomics fingerprints to bladder carcinoma 126
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 126
Studi sul Meccanismo di Stereospecificità della Lipasi Candida Rugosa nella Idrolisi di Esteri di Piridil-1-etanoli 125
Integrating Crystallography into Early Metabolism Studies 125
Groupings of organic substituents 125
Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH 125
Syntehesis and Structural Studies of Cationic Bis- and Tris(pyrazol-1-yl)methane Acyl and Methul Complexex of Ruthenium(II); Localizazion of the counterion in Solution by NOESY NMR Spectroscopy. 124
GBR Compounds and Mepyramines as Cocaine Abuse Therapeutics: Chemometric Studies on Selectivity Using Grid Independent Descriptors (GRIND) 124
MetaSite: understanding CYP antitarget modelling for early toxicity detection 124
Comparison of chemometric methods for QSAR 124
ADME-Space: A new tool for medicinal chemists to explore ADME properties 124
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 124
VHL-Modified PROteolysis TArgeting Chimeras (PROTACs) as a Strategy to Evade Metabolic Degradation in In Vitro Applications 124
A comparative chemometric study of QSAR descriptors 123
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 123
BDDCS Class Prediction for New Molecular Entities 122
BioGPS descriptors for rational engineering of enzyme promiscuity and structure based bioinformatic analysis 122
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization 121
Molecular fields in quantitative structure-permeation relationships: the VolSurf approach 121
Comparison of chemometric methods in toxicology 121
Determination of tocopherols and their metabolites by liquid-chromatography coupled with tandem mass spectrometry in human plasma and serum 121
GOLPE: An Advanced Chemometric Tool for 3D-QSAR Problems 121
Structural Requirements for Binding to Cannabinoid Receptors 120
Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases 120
Metabolism study and biological evaluation of bosentan derivatives 120
Improving the prediction of the brain disposition for orally administered drugs using BDDCS 120
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist 119
Characterization of Protein-Binding Sites and Ligands Using Molecular Interaction Fields 118
Indomethacin-based PROTACs as pan-coronavirus antiviral agents 118
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds 117
Comparative Binding Energy (COMBINE) Analysis on a Series of Glycogen Phosphorylase Inhibitors. Comparison with GRID/GOLPE Models 117
A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands and Proteins (FLAP): Theory and Application 117
Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs 116
Structural Differences of Matrix Metalloproteinases with Potential Implications for Inhibitor Selectivity Examined by the GRID/CPCA Approach 116
Structure-based Rationalization of Antitumor Drug Mechanism of Action by a MIF Approach 116
Mining large chemical spaces in lead and drug discovery 116
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 116
Natural and Synthetic Xanthones as Monoamine Oxidase Inhibitors: Biological Assay and 3D‐QSAR 115
Chemometric approach to a QSAR study of peptides behaving as NK-2 receptor antagonists 115
Arachidonic acid to docosahexaenoic acid ratio (AA/DHA): a strong clinical outcome predictor in DHA-based nutritional therapy of pediatric NASH 115
A computational study toward the “personalized” activity of alternariol – Does it matter for safe food at individual level? 115
GRID-Derived Molecular Interaction Fields for Predicting the Site of Metabolism in Human Cytochromes 114
D-optimal designs in QSAR 114
Chemometric investigation on peptide QSAR 114
GRID-Based Three-Dimensional Pharmacophores I: FLAPpharm, a Novel Approach for Pharmacophore Elucidation 114
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields 114
Experimental design and multivariate calibration in the development, set-up and validation of a differential pulse polarographic and UV spectrophotometric method for the simultaneous plasmatic determination of the therapeutic ... 113
GRIND/ALMOND investigations on CysLT(1) receptor antagonists of the quinolinyl(bridged)aryl type 113
QSAR study and VolSurf characterization of anti-HIV quinolone library 113
The antibacterial activity of quinolones against E.coli: a chemometric study 113
Quantitative structure–property relationship modeling of ruthenium sensitizers for solar cells applications: novel tools for designing promising candidates 113
Transporter-Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target 112
Getting Insights into Structural and Energetic Properties of Reciprocal Peptide-Protein Interactions 111
Structure-Metabolism Relations, and the Challenge of Predicting Biotransformation 111
CROMATIC: Cross-Relationship Map of Cavities from Coronaviruses 110
Antileishmanial Chalcones: Statistical Design, Synthesis, andThree-Dimensional Quantitative Structure-Activity Relationship Analysis 110
A new set of Principal Properties for Heteroaromatics obtained by GRIDQuant. Struct.-Act. Relat., 15, 108-120 (1996). 110
A liquid chromatography-high resolution mass spectrometry method for the determination of thirty-three per- and polyfluoroalkyl substances in animal liver 110
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 109
Totale 13.172
Categoria #
all - tutte 135.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.609 0 0 0 0 94 33 23 698 68 38 262 393
2022/20234.592 315 788 85 386 390 576 32 239 1.531 32 157 61
2023/20241.577 119 178 88 32 36 15 247 22 249 63 265 263
2024/20254.098 97 422 106 213 560 209 134 280 876 252 629 320
2025/20268.831 635 681 414 1.181 1.175 781 1.457 477 966 728 213 123
2026/20273.306 199 410 529 1.872 296 0 0 0 0 0 0 0
Totale 30.046